Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 7.87 B7.81 B7.75 B10.38 B7.63 B8.98 B 34.75 B Research & development —————— — Operating income 7.98 B8.17 B8.11 B5 B8.24 B7.18 B 28.53 B Non-Operating Income, Total 121 M79 M92 M-185 M477 M36 M 420 M Interest expense, net of interest capitalized 1.63 B1.64 B1.66 B1.76 B1.94 B1.99 B 7.35 B Non-Operating Income, excl. Interest Expenses -1.63 B-1.64 B-1.66 B-1.76 B-1.94 B-1.99 B -7.35 B Unusual income/expense 121 M79 M92 M-185 M477 M36 M 420 M Pretax income 6.47 B6.61 B6.53 B3.06 B6.78 B5.27 B 21.65 B Equity in earnings 6 M-3 M-6 M3 M5 M44 M 46 M Taxes 1.49 B1.49 B1.47 B615 M1.64 B1.32 B 5.05 B Non-controlling/minority interest 104 M118 M106 M106 M101 M114 M 427 M After tax other income/expense —————— — Net income before discontinued operations 4.88 B5 B4.95 B2.34 B5.04 B3.83 B 16.17 B Discontinued operations —————— — Net income 4.88 B5 B4.95 B2.34 B5.04 B3.83 B 16.17 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 4.88 B5 B4.95 B2.34 B5.04 B3.83 B 16.17 B Basic earnings per share (Basic EPS) 1.161.181.170.551.20.92 3.84 Diluted earnings per share (Diluted EPS) 1.151.181.170.561.20.92 3.85 Average basic shares outstanding 4.22 B4.22 B4.23 B4.23 B4.21 B4.17 B — Diluted shares outstanding 4.23 B4.23 B4.23 B4.23 B4.21 B4.17 B — EBITDA 8.71 B8.93 B8.85 B8 B9.08 B— — EBIT 7.98 B8.17 B8.11 B5 B8.24 B7.18 B 28.53 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 734 M754 M749 M3 B836 M— —